ECMO Use in Neonates with Hypoxic–Ischemic Encephalopathy: A State-of-the-Art Narrative Review of Feasibility, Efficacy, and Safety
American Journal of Perinatology · 01.12.2025 · 42 (16) · 2104-2110
DOI: 10.1055/a-2632-9833 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Perinatology, erschienen am 01.12.2025. Verfasst von Efren Diaz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatal-Perinatal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Hypoxia-Ischemia, Brain. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Extracorporeal membrane oxygenation (ECMO) is an important rescue strategy for neonates with severe cardiorespiratory failure, yet its role in the management of hypoxic–ischemic encephalopathy (HIE) remains subject to debate. Historically, clinicians have been reluctant to offer ECMO to infants with significant neurological injury because of concerns related to poor neurodevelopmental outcomes and elevated risk of complications such as hemorrhage and stroke. Over the past two decades, however, accumulating evidence has suggested that many neonates with HIE not only tolerate ECMO well but may also achieve meaningful survival and functional recovery. In this state-of-the-art narrative review, we surveyed and synthesized observational studies, retrospective cohorts, and case series published since 2000 that evaluated ECMO in neonates with HIE. While randomized controlled trials dedicated exclusively to this population remain scarce, the available data indicate that ECMO can be safely implemented alongside standard therapies—including therapeutic hypothermia—without uniformly prohibitive rates of bleeding or adverse neurodevelopment. Although small sample sizes and single-center experiences limit the strength of these conclusions, survival rates in combined TH-ECMO cohorts are often reported above 80 to 90%, with a substantial proportion of survivors demonstrating acceptable early neurodevelopmental outcomes. Overall, the growing clinical acceptance of ECMO in HIE highlights the need for careful, individualized assessment of benefits and risks, as well as transparent discussions with families. Future multicenter collaborations focusing on robust longitudinal follow-up and evidence-based protocols will be essential to guide best practices and optimize outcomes for this high-risk neonatal population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Neonatal-Perinatal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
- Children's Health System, Dallas, Texas.
- Division of Neonatal-Perinatal Medicine, University of Washington, Seattle, Washington.
ORCID-Profile: Efren Diaz
Zitieren
APA
Diaz, E., Lemus, R., Ahmed, S. T., Couch, S., Chalak, L., Digeronimo, R., & Makkar, A. (2025). ECMO Use in Neonates with Hypoxic–Ischemic Encephalopathy: A State-of-the-Art Narrative Review of Feasibility, Efficacy, and Safety. American Journal of Perinatology, 42(16), 2104-2110. https://doi.org/10.1055/a-2632-9833
Vancouver
Diaz E, Lemus R, Ahmed ST, Couch S, Chalak L, Digeronimo R, et al. ECMO Use in Neonates with Hypoxic–Ischemic Encephalopathy: A State-of-the-Art Narrative Review of Feasibility, Efficacy, and Safety. American Journal of Perinatology. 2025;42(16):2104-2110. doi:10.1055/a-2632-9833
BibTeX
@article{Diaz2025,
author = {Diaz, Efren and Lemus, Rafael and Ahmed, Syed Talha and Couch, Stephen and Chalak, Lina and Digeronimo, Robert and Makkar, Abhishek},
title = {ECMO Use in Neonates with Hypoxic–Ischemic Encephalopathy: A State-of-the-Art Narrative Review of Feasibility, Efficacy, and Safety},
journal = {American Journal of Perinatology},
year = {2025},
volume = {42},
number = {16},
pages = {2104--2110},
doi = {10.1055/a-2632-9833}
}
EUVIMED